MarketPeel
Insider Trading Intelligence
Pricing
…
MC

Mark Coleman

AXSM
DIRECTOR · AXSOME THERAPEUTICS, INC. · CIK 0001658379
FILING MIX · LIFETIME57%/43%
BUYS
29
SELLS
22
TOTAL VALUE
$13.14M
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
30,389
AVG SELL PX
$131.46
TRADE KIND
SHOWING 51 / 51
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons · 12 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Mark Coleman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+60.00%-1.16%+0.48%-1.64%+0.10%—
14d15+40.00%-4.04%+0.56%-4.61%-3.67%—
30d15+40.00%-2.23%+1.60%-3.83%-4.86%—
60d15+53.33%+0.53%+4.25%-3.72%-2.77%—
90d15+40.00%+4.38%+5.70%-4.12%-1.38%—
180d15(1 pending)+42.86%+15.83%+8.94%+6.89%+14.44%—
1y15(4 pending)+18.18%+48.74%+14.47%+26.41%+23.69%—
2y15(7 pending)+37.50%+80.98%+22.54%+16.33%+18.55%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AXSM · 30,389 shares · as of Jun 10, 2026
0105,607211,214316,821422,428202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 29 buys / 22 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
643$249.00$160.1K30,389Jun 10, 2026Jun 10, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
1,429——31,032Jun 8, 2026Jun 10, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
1,429——0Jun 8, 2026Jun 10, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,721——1,721Jun 5, 2026Jun 9, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,537$223.39$1.24M29,603Jun 2, 2026Jun 2, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,000$230.30$1.38M35,140Jun 1, 2026Jun 2, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,000$233.46$1.40M41,140May 29, 2026Jun 2, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
25,000$161.11$4.03M47,140Feb 26, 2026Feb 27, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
6,250$4.95$30.9K72,140Feb 23, 2026Feb 25, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
6,250——7,721Feb 23, 2026Feb 25, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
12,485——13,971Feb 20, 2026Feb 23, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
12,485$4.95$61.8K65,890Feb 20, 2026Feb 23, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
5,193$8.02$41.6K53,405Feb 10, 2026Feb 10, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
5,193——0Feb 10, 2026Feb 10, 2026 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
800$127.20$101.8K47,437Sep 8, 2025Sep 9, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
287$127.30$36.5K47,724Sep 8, 2025Sep 9, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
488$127.40$62.2K48,212Sep 8, 2025Sep 9, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,166——3,166Jun 6, 2025Jun 10, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,429——1,429Jun 6, 2025Jun 10, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,750$103.43$387.9K46,637May 28, 2025May 29, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,750$105.47$395.5K50,387May 27, 2025May 29, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
3,000$107.49$322.5K54,137May 20, 2025May 20, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
9,127$9.00$82.1K57,137Jan 3, 2025Jan 6, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
9,127——0Jan 3, 2025Jan 6, 2025 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
33,410$5.94$198.5K48,010Nov 19, 2024Nov 20, 2024 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
33,410——0Nov 19, 2024Nov 20, 2024 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,799——5,799Jun 7, 2024Jun 11, 2024 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,248$75.14$394.3K14,600May 29, 2024May 29, 2024 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,249$75.21$394.8K19,848May 28, 2024May 29, 2024 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
11,016$3.67$40.4K36,113Sep 15, 2023Sep 15, 2023 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
18,572$75.18$1.40M403,856Sep 15, 2023Sep 15, 2023 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
11,016$75.19$828.2K25,097Sep 15, 2023Sep 15, 2023 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
11,016——0Sep 15, 2023Sep 15, 2023 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,681——5,681Jun 2, 2023Jun 6, 2023 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,870——2,870Mar 2, 2023Mar 6, 2023 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
17,501——0Jan 3, 2023Jan 4, 2023 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
17,501$1.30$22.8K25,097Jan 3, 2023Jan 4, 2023 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,976——16,976Jun 3, 2022Jun 7, 2022 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALE
3,496——17,501Mar 15, 2022Mar 17, 2022 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
3,496$1.30$4.5K7,596Mar 15, 2022Mar 17, 2022 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,798——2,798Mar 4, 2022Mar 8, 2022 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
409$35.07$14.3K421,407Nov 18, 2021Nov 22, 2021 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
1,021$35.10$35.8K422,428Nov 18, 2021Nov 22, 2021 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,325——7,325Jun 4, 2021Jun 8, 2021 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
500$58.15$29.1K420,998May 12, 2021May 13, 2021 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,201——1,201Mar 5, 2021Mar 9, 2021 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
SALEGRANT
Gift
397,998——5,700Aug 19, 2020Aug 20, 2020 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Gift
397,998——397,998Aug 19, 2020Aug 20, 2020 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASE
650$78.50$51.0K403,698Jun 29, 2020Jun 30, 2020 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
13,000——13,000Jun 5, 2020Jun 5, 2020 ↗View →
AXSM
AXSOME THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,308——3,308Mar 17, 2020Mar 19, 2020 ↗View →
Other insiders · AXSM
Loading peer insiders…
About this filer
CIK 0001658379
ROLE
Director
PRIMARY
AXSM
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001658379DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback